Krishna Institute of Medical Sciences Limited

BSE: KIMS543308ISIN INE967H01025

Healthcare
Hospital
BSE 500

Share price

₹739.85+9.35 (+1.28%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

Splits and bonuses

13 Sep 2024 · Split 5:1 (₹10 → ₹2)

52W high: ₹858.15
52W low: ₹575.55
Off 52W high: -13.79%
1M return: +5.40%
3M return: -8.26%
6M return: +5.54%
1Y return: +3.15%
20D avg volume: 26,464
50 DMA: ₹738.09
200 DMA: ₹727.20

Key ratios Consolidated

Market cap: ₹31,074 Cr
Current price: ₹739.85
52W high / low: ₹858.15 / ₹575.55
Face value: ₹2.00
P/E: 159.85
P/B: —
EPS (TTM): ₹4.63
Book value / share: —
ROE: —
ROCE: 8.20%
Operating margin: —
Net margin: —
Debt / equity: 1.27
Net debt: ₹3,189 Cr
Interest cover: 2.64
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 30.7 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	1,180	1,075	997.70	960.70	871.60	796.90	772.40	777.30	688.40	633.80	605.84	652.48
	16.40	9.70	5.20	4.20	7.10	4.50	17.80	5.00	4.60	3.81	3.25	2.88
	1,196	1,084	1,003	964.90	878.70	801.40	790.20	782.30	693.00	637.60	609.09	655.36
	1,140	1,021	934.30	867.80	765.00	678.20	655.60	620.10	565.90	537.48	506.52	516.73
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	260.90	235.40	211.20	203.50	191.70	169.20	169.80	156.60	144.80	135.17	124.45	142.53
	212.60	179.90	176.30	174.50	151.00	134.10	127.50	119.20	118.60	108.53	104.25	105.67
	83.40	68.10	56.80	45.00	32.60	26.70	25.70	19.90	17.90	16.36	12.43	8.91
	100.80	85.00	78.70	66.10	53.40	52.60	44.70	41.00	39.00	46.30	35.38	32.61
	498.80	455.40	425.60	387.00	344.00	297.70	—	—	—	—	—	—
	55.60	63.10	68.60	97.10	113.70	123.20	134.60	162.20	127.10	100.12	102.57	138.64
	0.00	-10.90	0.00	-0.30	0.00	10.80	0.00	0.00	0.00	0.00	0.00	-0.02
	55.60	52.20	68.60	96.80	113.70	134.00	134.60	162.20	127.10	100.12	102.57	138.62
	19.20	21.70	16.70	24.80	28.70	27.90	42.10	41.50	31.90	28.50	25.90	37.32
	37.40	33.10	51.90	72.00	85.00	106.10	92.50	120.70	95.20	71.49	76.55	101.29
	1.04	1.06	1.33	1.67	1.96	2.54	2.22	2.68	10.82	8.18	8.98	11.50
Key metrics
	239.80	205.30	204.10	207.90	199.70	213.30	205.00	223.10	184.00	162.78	150.38	180.14
	20.30%	19.10%	20.50%	21.60%	22.90%	26.80%	26.50%	28.70%	26.70%	25.70%	24.80%	27.60%
	3.20%	3.10%	5.20%	7.50%	9.80%	13.30%	12.00%	15.50%	13.80%	11.30%	12.60%	15.50%
	—	1.80%	—	2.60%	—	3.30%	—	—	—	—	—	—
	35.30%	34.80%	29.20%	23.60%	26.60%	25.70%	27.50%	19.10%	—	—	—	—
	-56.00%	-68.80%	-43.90%	-40.30%	-10.70%	48.40%	20.80%	19.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21
Income statement
	4,212	3,905	3,035	2,498	2,198	1,651	1,330
	35.50	26.20	31.90	13.06	25.87	20.26	10.16
	4,248	3,931	3,067	2,511	2,224	1,671	1,340
	3,964	3,588	2,520	2,051	1,753	1,224	1,061
	0.00	0.00	0.00	—	—	—	282.64
	911.00	841.80	640.40	536.87	474.49	367.50	—
	743.30	681.70	499.50	422.37	346.44	261.91	220.21
	253.30	202.50	90.30	47.03	30.55	16.03	32.50
	330.60	283.20	177.20	146.55	129.26	72.67	69.54
	1,767	1,612	1,126	—	—	—	—
	284.40	342.50	547.30	459.91	470.08	447.34	279.01
	-11.20	-11.20	10.80	0.00	14.83	0.00	0.00
	273.20	331.30	558.10	459.91	484.91	447.34	279.01
	82.40	91.90	143.30	123.63	119.09	114.32	73.54
	194.40	242.00	414.80	336.01	365.81	343.80	205.48
	5.10	6.03	9.61	38.75	42.03	41.88	26.87
Key metrics
	857.10	817.00	825.60	653.49	644.72	536.04	381.05
	20.35%	20.90%	27.20%	26.20%	29.30%	32.50%	28.70%
	4.61%	6.20%	13.70%	13.50%	16.60%	20.80%	15.50%
	—	8.20%	13.20%	—	—	—	—
	30.90%	28.60%	21.50%	13.70%	33.10%	24.10%	—
	-51.92%	-41.70%	23.40%	-8.10%	6.40%	67.30%	—
	—	-917.10	-427.10	—	—	—	—
	—	2.11	1.40	—	—	—	—
	—	1.27	1.06	—	—	—	—
	—	3,189	2,501	—	—	—	—
	—	30.7	22.9	—	—	—	—
Balance sheet
	—	7,759	5,736	—	—	—	—
	—	937.40	697.30	—	—	—	—
	—	55.40	56.00	—	—	—	—
	—	554.20	395.40	—	—	—	—
	—	96.90	64.00	—	—	—	—
	—	56.80	37.70	—	—	—	—
	—	4,186	2,199	—	—	—	—
	—	322.80	269.10	—	—	—	—
	—	1,239	836.20	—	—	—	—
	—	3,244	2,557	—	—	—	—
	—	571.40	269.50	—	—	—	—
	—	2,673	2,287	—	—	—	—
	—	2,558	2,419	—	—	—	—
Cash flow
	—	510.80	581.80	—	—	—	—
	—	-1,452	-1,116	—	—	—	—
	—	940.30	543.10	—	—	—	—
	—	1,428	1,009	—	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	483.60	456.20	441.90	430.00	373.40	345.90	347.50	363.30	327.40	304.85	302.06	316.25
	30.70	17.60	14.30	12.50	12.20	24.20	20.60	6.60	5.30	3.90	4.23	3.57
	514.30	473.80	456.20	442.50	385.60	370.10	368.10	369.90	332.70	308.74	306.29	319.81
	425.50	378.00	358.40	356.10	305.90	260.30	266.20	270.80	251.10	241.28	228.58	230.79
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	99.90	91.00	86.00	91.70	78.10	70.70	75.20	69.10	64.50	59.43	61.28	67.19
	84.90	72.00	74.40	76.10	68.20	58.20	57.10	59.60	61.50	56.12	54.15	55.86
	32.80	26.80	21.60	17.80	12.50	8.10	6.70	4.60	3.80	2.31	1.22	0.05
	27.30	25.50	22.60	20.50	17.50	15.10	14.90	14.00	13.70	20.41	12.78	12.79
	184.50	163.10	158.30	156.30	131.90	107.60	—	—	—	—	—	—
	88.80	95.80	97.80	86.40	79.70	109.80	101.90	99.10	81.60	67.47	77.71	89.02
	0.00	-6.70	0.00	-0.30	0.00	10.80	—	—	—	—	—	—
	88.80	89.10	97.80	86.10	79.70	120.60	101.90	99.10	81.60	67.47	77.71	89.02
	22.30	23.20	25.30	22.60	20.90	27.00	25.40	26.90	20.90	19.27	19.35	22.86
	66.50	65.90	72.50	63.50	58.80	93.60	76.50	72.20	60.70	48.19	58.35	66.16
	1.66	1.65	1.81	1.59	1.47	2.34	1.91	1.80	7.58	6.02	7.29	8.27
Key metrics
	148.90	141.40	142.00	124.40	109.70	143.80	123.50	117.70	99.10	90.19	91.71	101.86
	30.80%	31.00%	32.10%	28.90%	29.40%	41.60%	35.50%	32.40%	30.30%	29.60%	30.40%	32.20%
	13.80%	14.40%	16.40%	14.80%	15.70%	27.10%	22.00%	19.90%	18.50%	15.80%	19.30%	20.90%
	—	3.10%	—	3.30%	—	4.50%	—	—	—	—	—	—
	29.50%	31.90%	27.20%	18.40%	14.10%	13.50%	15.00%	14.90%	—	—	—	—
	13.10%	-29.60%	-5.20%	-12.00%	-3.10%	94.20%	31.10%	9.10%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21
Income statement
	1,812	1,702	1,384	1,222	1,132	1,143	932.69
	75.10	56.60	56.70	15.53	23.50	24.17	9.62
	1,887	1,758	1,441	1,238	1,156	1,168	942.30
	1,518	1,398	1,048	919.41	818.19	796.55	688.04
	0.00	0.00	0.00	—	—	—	195.96
	368.60	346.80	279.50	253.57	230.82	259.42	—
	307.40	290.70	236.40	219.57	187.25	174.02	147.04
	99.00	78.70	23.20	3.66	1.15	4.47	14.78
	95.90	86.10	57.70	58.11	45.30	44.92	44.60
	662.20	609.60	455.90	—	346.93	—	—
	368.80	359.70	392.30	318.17	337.33	371.00	254.26
	-7.00	-7.00	10.80	—	—	—	—
	361.80	352.70	403.10	318.17	337.33	371.00	254.26
	93.40	92.00	100.20	82.83	84.84	92.64	65.61
	268.40	260.70	302.90	235.34	252.49	278.37	188.65
	6.71	6.52	7.57	29.41	31.55	35.04	25.20
Key metrics
	556.70	517.50	484.00	379.94	383.78	420.39	313.64
	30.73%	30.40%	35.00%	31.10%	33.90%	36.80%	33.60%
	14.81%	15.30%	21.90%	19.30%	22.30%	24.30%	20.20%
	—	11.60%	15.10%	—	—	—	—
	26.68%	22.90%	13.30%	8.00%	-1.00%	22.60%	—
	-10.86%	-13.90%	28.70%	-6.80%	-9.30%	47.60%	—
	—	-64.00	-58.10	—	—	—	—
	—	1.12	0.97	—	—	—	—
	—	0.60	0.33	—	—	—	—
	—	1,428	681.90	—	—	—	—
	—	43.8	31.4	—	—	—	—
Balance sheet
	—	4,285	3,189	—	—	—	—
	—	433.80	299.40	—	—	—	—
	—	25.10	26.10	—	—	—	—
	—	278.40	187.40	—	—	—	—
	—	39.80	26.30	—	—	—	—
	—	27.00	0.00	—	—	—	—
	—	1,398	723.80	—	—	—	—
	—	113.60	94.40	—	—	—	—
	—	564.70	358.70	—	—	—	—
	—	1,453	708.00	—	—	—	—
	—	349.60	130.90	—	—	—	—
	—	1,103	577.10	—	—	—	—
	—	2,429	2,168	—	—	—	—
Cash flow
	—	292.60	293.60	—	—	—	—
	—	-955.90	-626.60	—	—	—	—
	—	662.30	338.60	—	—	—	—
	—	356.60	351.70	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +14.55%
Sales CAGR 5Y: +12.78%
Profit CAGR 3Y: +1.07%
Profit CAGR 5Y: +6.68%
Sales YoY (TTM): +26.68%
Profit YoY (TTM): -10.86%

Consolidated

Sales CAGR 3Y: +21.12%
Sales CAGR 5Y: +24.04%
Profit CAGR 3Y: -12.87%
Profit CAGR 5Y: +3.33%
Sales YoY (TTM): +30.90%
Profit YoY (TTM): -51.92%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 32.66%

Quarter	September 2026	June 2026	March 2026
Promoter %	32.66%	32.50%	32.50%

Holder	Type	Holding	Previous	Change
Bhaskara Rao Bollineni	Promoter	25.02%	25.02%	0.00%
Bluebridge Capital Private Limited	Promoter	5.76%	5.76%	0.00%
Sbi Small Cap Fund	Public	4.85%	5.17%	-0.32%
Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund	Public	4.76%	4.50%	+0.26%
Kotak Small Cap Fund	Public	4.42%	3.61%	+0.81%
Hdfc Small Cap Fund	Public	3.99%	3.98%	+0.01%
Bollineni Seenaiah Naidu	Public	3.93%	3.93%	0.00%
Invesco India Flexi Cap Fund	Public	3.57%	—	—
Amansa Holdings Private Limited	Public	2.15%	2.24%	-0.09%
Lilac Investments Limited	Public	1.87%	1.87%	0.00%
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund	Public	1.79%	1.95%	-0.16%
Sbi Life Insurance Co. Ltd	Public	1.71%	1.71%	0.00%
Rajyasri Bollineni	Promoter	1.64%	—	—
Nomura India Investment Fund Mother Fund	Public	1.42%	1.50%	-0.08%
Hdfc Life Insurance Company Limited	Public	1.26%	1.29%	-0.03%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Apollo Hospitals Enterprises Ltd.	1,23,324	8,577.00	56.78	19.50%	+19.24% TTM	+35.20% TTM	+9.78%
Max Healthcare Institute Limited	90,129	926.00	65.28	12.70%	+15.17% TTM	+1.73% TTM	-18.59%
Manipal Health Enterprises Limited	87,828	667.70	—	—	—	—	—
ASTER DM QUALITY CARE LIMITED	62,665	718.90	172.72	10.20%	+15.70% TTM	+3.89% TTM	+4.39%
Fortis Healthcare Ltd	59,710	790.90	55.79	12.00%	+17.50% TTM	+18.62% TTM	-22.35%
Narayana Hrudayalaya Limited	39,427	1,929.30	45.89	11.40%	+71.40% TTM	+1.61% TTM	+5.41%
Global Health Limited	37,682	1,401.45	61.46	15.00%	+26.18% TTM	+9.16% TTM	+12.21%
Krishna Institute of Medical Sciences Limited	31,074	739.85	159.85	8.20%	+30.90% TTM	-51.92% TTM	+3.15%
Dr. Agarwal's Health Care Limited	16,618	524.15	89.77	9.70%	—	—	+1.80%
Rainbow Children's Medicare Limited	12,990	1,278.95	43.51	16.80%	+22.83% TTM	+17.12% TTM	-8.02%
PARK MEDI WORLD LIMITED	9,958	230.55	—	18.10%	—	—	—
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED	9,900	1,027.45	54.50	11.00%	+50.40% TTM	+19.12% TTM	+25.09%
HealthCare Global Enterprises Limited	9,286	621.95	279.19	6.90%	+13.77% TTM	-19.23% TTM	—
Jupiter Life Line Hospitals Limited	9,178	279.95	49.57	13.80%	+16.71% TTM	-6.85% TTM	-9.74%
Paras Healthcare Limited	8,135	751.85	—	—	—	—	—
Kovai Medical Center & Hospital Ltd S	6,561	5,996.35	25.97	20.60%	+14.96% TTM	+16.29% TTM	-1.95%
Artemis Medicare Services Limited	4,758	300.60	41.36	13.70%	+14.77% TTM	+21.46% TTM	+22.59%
Indraprastha Medical Corporation Lt S	3,092	337.25	16.09	30.70%	+10.72% TTM	+9.95% TTM	-44.21%
Dr.Agarwals Eye Hospital Ltd. S	2,616	5,413.80	34.33	16.10%	+20.01% TTM	+31.87% TTM	+2.39%
KMC Speciality Hospitals India Limited S	2,453	150.40	43.98	24.60%	+35.05% TTM	+137.83% TTM	+118.35%
Shalby Limited	1,336	123.70	35.06	7.90%	+7.27% TTM	+17,422.73% TTM	-49.15%
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED	1,260	159.75	75.29	8.60%	—	—	—
GPT Healthcare Limited S	1,152	140.45	24.38	16.40%	+18.07% TTM	-0.78% TTM	-5.48%
Rays of Belief Limited	528	252.45	—	—	—	—	—
ASARFI HOSPITAL LIMITED	347	176.40	—	18.40%	—	—	+22.97%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Deviation Report - QIP4 Nov 2026 · Company Update / General
Deviation Report - Preferential Allotment4 Nov 2026 · Company Update / General
Preferential Allotment - Monitoring Agency Report4 Nov 2026 · Company Update / Monitoring Agency Report
QIP - Monitoring Agency Report4 Nov 2026 · Company Update / Monitoring Agency Report
Intimation of Merger of Wholly owned subsidiary i.e KHPL with its holding company i.e Krishna Institute of Medical Sciences Limited4 Nov 2026 · Company Update / Scheme of Arrangement
Reappointment of Dr. Abhinay Bollineni, Dr. Bhaskara Rao Bollineni and Ms. Dandamudi Anitha4 Nov 2026 · Company Update / Change in Management
Investor presentation4 Nov 2026 · Company Update / Investor Presentation
Press Release4 Nov 2026 · Company Update / Press Release / Media Release
Quarterly Result4 Nov 2026 · Result / Financial Results
Outcome of the Board Meeting4 Nov 2026 · Board Meeting / Outcome of Board Meeting
General Announcement1 Nov 2026 · Company Update / General
The Company ahs acquired 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli)29 Oct 2026 · Company Update / Acquisition
The Company ahs entered into definitive agreements for acquiring 51% stake in Sarvottam Healthcare Private Limited29 Oct 2026 · Company Update / Acquisition
Dr. Bhaskara Rao Bollineni - Founder & Managing Director, Dr. Abhinay Bollineni - Executive Director and CEO, and Mr. Sachin Salvi - Chief Financial Officer, would participate in a conference ....29 Oct 2026 · Company Update / Analyst / Investor Meet
General Announcement28 Oct 2026 · Company Update / General
Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the unaudited ....26 Oct 2026 · Board Meeting / Board Meeting
JM Financial Annual India Conference19 Oct 2026 · Company Update / Analyst / Investor Meet
Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 30.09.202610 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
General Update8 Oct 2026 · Company Update / General
General Update7 Oct 2026 · Company Update / General
Intimation U/r 306 Oct 2026 · Company Update / Acquisition
Intimation U/r 306 Oct 2026 · Company Update / Acquisition
Intimation under regulation 30 of SEBI(LODR)6 Oct 2026 · Company Update / Acquisition
Intimation u/r 30-acquistion of upto 51 % stake in Insignia6 Oct 2026 · Company Update / Acquisition
Closure of Trading Window for consideration of unaudited financial results for 2nd Quarter and half-year ending 30th September, 2026.26 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd23 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Anand Rathi Annual Flagship Conference G-200 Summit 202615 Sep 2026 · Company Update / Analyst / Investor Meet
J.P. Morgan India Conference15 Sep 2026 · Company Update / Analyst / Investor Meet
The Company has entered into Operations and Management Agreement with Sarvottam Health Care Private Limited, Kakinada, Andhra Pradesh.10 Sep 2026 · Company Update / Memorandum of Understanding /Agreements
Intimation of schedule of Analyst / Institutional Investor Meeting.7 Sep 2026 · Company Update / Analyst / Investor Meet
Voting results and Scrutinizer''s Report for the 24th AGM held on 27.08.202630 Aug 2026 · AGM/EGM / AGM
Proceedings of 24th Annual General Meeting of the Company27 Aug 2026 · AGM/EGM / AGM
Clarification regarding article appearing in Dealstreetasia.com26 Aug 2026 · Company Update / General
KIMS has entered into Operations and Management agreement with Aurevia Hospitals Private Limited20 Aug 2026 · Company Update / General
Allotment of Warrants20 Aug 2026 · Company Update / Allotment of Equity Shares
Transcript of earnings conference call with investors held on 04 August, 20268 Aug 2026 · Company Update / Earnings Call Transcript
Intimation of receipt of the In-Principal Approval for the issue and allotment of warrants to promoters/promoters group on a preferential basis7 Aug 2026 · Company Update / General
Copy of Newspaper Publication towards intimation of notice of 24th Annual General Meeting of the Company.6 Aug 2026 · Company Update / Newspaper Publication
Letter to Shareholders Regarding Annual Report5 Aug 2026 · Company Update / General
BRSR for the FY 2025-265 Aug 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)

Corporate actions

Purpose	Ex date	Record date	Payment date
Stock Split From Rs.10/- to Rs.2/-	13 Sep 2024	13 Sep 2024	—

Board meetings

4 Nov 2026 Board Meeting - Financial Results
3 Aug 2026 Board Meeting - Financial Results